The occurrence of vancomycin-resistant enterococci in hematological patients in relation to antibiotic use

New Microbiologica

Volumn 25, Issue 2, 2002, Pages 205-212

  Kolar M ^a   Vagnerova I ^a   Latal T ^a   Urbanek K ^a   Typovska H ^a   Hubacek J ^a   Papajik T ^a   Raida, L ^a   Faber, E ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Hematological patients; Influence of antibiotic application; Vancomycin resistant enterococci

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; CLASSIFICATION; DRUG EFFECT; ENTEROCOCCUS; GENETICS; HEMATOLOGIC DISEASE; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; RETROSPECTIVE STUDY;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; HEMATOLOGIC DISEASES; HUMANS; RETROSPECTIVE STUDIES; VANCOMYCIN RESISTANCE;

EID: 0036527615     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. WHO COLLABORATION CENTRE FOR DRUG STATISTICS METHODOLOGY (1996). Anatomical therapeutic chemical (ATC) index (including defined daily doses (DDDs) for plain substances) Oslo.
2. ARTHUR, M., REYNOLDS, P.E., DEPARDIEU, F., EVERS, S., DUTKA-MALEN, S., QUINTILIANI, R.JR., and COURVALIN, P. (1996). Mechanisms of glycopeptide resistance in enterococci. The Journal of Infection, 32, 11-16.
3. BERGMAN, U., CHRISTENSON, T., JANSSON, B., and WIHOLM, B.E. (1980). Auditing drug utilization by means of defined daily dose per bedday. A methodological study. European Journal of Clinical Pharmacology, 17, 183-187.
4. Bow, E.J. (1998). Infection risk and cancer chemotherapy: the impact of the chemotherapeutic regimen in patients with lymphoma and solid tissue malignancies. Journal of Antimicrobial Chemotherapy, 41D, 1-5.
5. FACKLAM, R.R., and COLLINS, M.D. (1989). Identification of Enterococcus species isolated from human infections by conventional test scheme. Journal of Clinical Microbiology, 27, 731-734.
6. FINES, M., PERICHON, B., REYNOLDS, P., SAHM, D.F., and COURVALIN, P. (1999). VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Journal of Antimicrobial Chemotherapy, 43, 2161-2164.
7. GAYNES, R., and EDWARDS, J. (1996) The National Nosocomial Infection Surveillance (NNIS) System. Nosocomial vancomycin resistant enterococci (VRE) in the United States, 1989-1995: the first 1000 isolates (abstract). In: The Sixth Annual Meeting of The Society for Healthcare Epidemiology of America; April 1996; Washington, DC. Infection Control and Hospital Epidemiology, 17, P18.
8. GIN, A.S., and ZHANEL, G.G. (1996). Vancomycin-resistant enterococci. Annals of Pharmacotherapy, 30, 615-624.
9. HEATH, C.H., BLACKMORE, T.K., and GORDON, D.L. (1996). Emerging resistance in Enterococcus sp. Medical Journal of Australia, 164, 116-120.
10. HUGH, R., and LEIFSON, E. (1953). The taxonomic significance of fermentative versus oxidative metabolism of carbohydrates by various Gram negative bacteria. Journal of Bacteriology, 66, 24-26.
11. KOLÁR, M., and LÁTAL, T. (1999). Implementation of a practical antibiotic policy in the Czech Republic. Infection Control and Hospital Epidemiology, 20, 440-443.
12. MOREILLON, P. (1997). Emerging antibiotic resistance in bacterial pathogens. In Klastersky, J.A., Febrile neutropenia. Springer-Verlag, Berlin Heidelberg.
13. MURRAY, B.E. (1998). Diversity among multidrug-resistant enterococci. Emerging Infectious Diseases, 4, 37-47.
14. th edn. Approved Standard M7-A4. Wayne PA.
15. OPPENHEIM, B.A. (1998). The changing pattern of infection in neutropenic patients. Journal of Antimicrobial Chemotherapy, 41D, 7-11.
16. PERICHON, B., REYNOLDS, P., and COURVALIN, P. (1997). VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrobial Agents and Chemotherapy, 41, 2016-2018.
17. ROLSTON, K.V.I., RAAD, I., WHIMBEY, E., and BODEY, GP. (1997). The changing spectrum of bacterial infections in febrile neutropenic patients. In Klastersky, J.A., Febrile neutropenia. Springer-Verlag, Berlin Heidelberg.
18. SPELLER, D.C.E., LYNN, W.A., and ROGERS, T.R. (1995). Glycopeptide resistance in gram-positive bacteria. Clinical Microbiology and Infection, 1, 54-59.
19. VLČEK, J., ŠLESZAROVÁ, P., POZLEROVÁ, E., KOTLÁŘ, J., BLÁHA, V., and MASHBURN, J. (2000). The antibiotic resistance survey: A preliminary report on the drug utilization evaluation study at the University teaching hospital, Charles University, Czech Republic. Pharmacoepidemiology and Drug Safety, 9 237-243.
20. WARNOCK, D.W. (1998). Fungal infections in neutropenia: current problems and chemotherapeutic control. Journal of Antimicrobial Chemotherapy, 41D, 95-105.